 In December 2018, AMAG announced it would acquire Perosphere Pharmaceuticals Inc.The company's research and tests focus on iron deficiency anemia and related intravenous drugs.In June 2009, the company's main product Ferumoxytol, an oral medication used on adult patients with chronic kidney disease, was approved by US Food and Drug Administration.